rethinkPeptides Search
Menu
Research citation

Cagrilintide-Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes.

evidence

This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.

Read the original research

Cagrilintide-Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes.

The New England journal of medicine, 393(7), 648-659

Citation

Davies, Melanie J; Bajaj, Harpreet S; Broholm, Christa; Eliasen, Astrid; Garvey, W Timothy; le Roux, Carel W; Lingvay, Ildiko; Lyndgaard, Christian Bøge; Rosenstock, Julio; Pedersen, Sue D. (2025). Cagrilintide-Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes.. The New England journal of medicine, 393(7), 648-659. https://doi.org/10.1056/NEJMoa2502082